NEW Funding Opportunity Announcement: Enhanced State Surveillance of Opioid-Involved Morbidity and Mortality

NEW Funding Opportunity Announcement: Enhanced State Surveillance of Opioid-Involved Morbidity and Mortality

CDC released CDC-RFA-CE16-1608, Enhanced State Surveillance of Opioid-Involved Morbidity and Mortalityto equip states to improve the timeliness of surveillance of opioid-involved morbidity and mortality.

CDC’s Injury Center intends to support up to 11 state health departments with high burden of drug overdose (i.e. states with high drug overdose death rates in 2014 or rapidly increasing drug overdose death rates from 2012 to 2014) over the 3-year project period, with an average award amount of $335,000 each year.

A desired outcome of the enhanced surveillance is to provide key stakeholders with more timely data on fatal and nonfatal opioid overdose and more detailed information on risk factors, which can inform prevention and response efforts. Improved quality and timeliness of surveillance data will support and inform ongoing activities to prevent and address prescription drug misuse, abuse, and overdose funded through CDC’s existing state programs.

State governments or their bona fide agents, including the District of Columbia, are eligible to apply.

Applications due: June 27, 2016. 
Letter of Intent due: May 13, 2016.

An informational conference call will be held on May 11, 2016 at 2:00 p.m. to understand the conceptual context of this FOA. The conference call can be accessed at (770) 488-3600 or (855) 644-0229; conference ID: 5740377.

The funding opportunity announcement can be found at www.grants.gov or on the Injury Center funding opportunities announcement page at www.cdc.gov/injury/fundedprograms/foa. Note that amendments to the announcement focus and application dates are possible. Please check for updates on grants.gov.